Roger Pomerantz's Net Worth
$19.1 Million
Who is Roger Pomerantz?
Roger Pomerantz has an estimated net worth of $19.1 Million. This is based on reported shares across multiple companies, which include Seres Therapeutics, Inc., Intec Pharma Ltd., Indaptus Therapeutics, Inc., CONTRAFECT Corp, Rubius Therapeutics, Inc., and Viracta Therapeutics, Inc..
SEC CIK
Roger Pomerantz's CIK is 0001614936
Past Insider Trading and Trends
2016 was Roger Pomerantz's most active year for acquiring shares with 20 total transactions. Roger Pomerantz's most active month to acquire stocks was the month of May. 2016 was Roger Pomerantz's most active year for disposing of shares, totalling 50 transactions. Roger Pomerantz's most active month to dispose stocks was the month of April. 2022 saw Roger Pomerantz paying a total of $1,665,000.00 for 687,418 shares, this is the most they've acquired in one year. In 2016 Roger Pomerantz cashed out on 1,360,965 shares for a total of $17,517,395.03, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -0.84% | -1.81K |
$9.00 | -$16,291.27 | 213.98K |
Scheduled
|
Sep 7
| ||
Form 4
| -5.48% | -12.52K |
$9.10 | -$113,949.53 | 215.79K |
Scheduled
|
Sep 5 - Sep 6
| ||
Form 4
|
—
|
0
|
$4.86 | -$8,381.89 | 228.3K |
Scheduled
|
Jul 11
| ||
Form 4
|
—
|
0
|
$4.91 | -$272,106.75 | 228.3K |
Scheduled
|
Jul 6 - Jul 10
| ||
Form 4
|
—
|
0
|
$4.93 | -$219,790.97 | 228.3K |
Scheduled
|
Jun 28 - Jun 29
| ||
Form 4
| -4.38% | -10.46K |
$4.94 | -$556,348.30 | 228.3K |
Scheduled
|
Jun 25 - Jun 27
| ||
Form 4
| -26.38% | -85.54K |
$9.28 | -$793,906.79 | 238.77K |
Scheduled
|
Jun 20 - Jun 22
| ||
Form 4
| -0.07% | -233.00 |
$9.00 | -$2,097.00 | 324.3K |
Scheduled
|
May 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| +14.15% | 40.24K |
$0.71 | $28,571.11 | 324.54K |
Jan 24
| |||
Form 4
| +54.77% | 100.6K |
$0.71 | $71,428.84 | 284.3K |
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
$17.86 | -$685,800.00 | 183.69K |
Scheduled
|
Jul 27
| ||
Form 4
|
—
|
0
|
$15.08 | -$2,534,844.16 | 183.69K |
Scheduled
|
Jul 5 - Jul 6
| ||
Form 4
|
—
|
0
|
$15.26 | -$1,652,384.53 | 183.69K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$16.62 | -$2,355,340.88 | 183.69K |
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
$15.61 | -$2,114,462.64 | 183.69K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$15.36 | -$287,071.29 | 183.69K |
Scheduled
|
May 24
| ||
Form 4
| +708.25% | 160.97K |
$0.71 | $114,285.15 | 183.69K |
May 18
| |||
Form 4
|
—
|
0
|
$12.51 | -$200,762.55 | 22.73K |
Scheduled
|
May 6
| ||
Form 4
|
—
|
0
|
$13.42 | -$1,508,157.17 | 22.73K |
Scheduled
|
May 4 - May 5
| ||
Form 4
|
—
|
0
|
$14.71 | -$1,885,366.32 | 22.73K |
Scheduled
|
May 2 - May 3
| ||
Form 4
|
—
|
0
|
$15.34 | -$270,213.24 | 22.73K |
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$13.84 | -$3,628,617.25 | 22.73K |
Scheduled
|
Apr 1 - Apr 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 22.73K |
—
|
—
| 22.73K |
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intec Pharma Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Indaptus Therapeutics, Inc. (INDP) Snapshot price: $1.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONTRAFECT Corp (CFRX) Snapshot price: $0.05
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 800 |
$1.24 | $992.00 | 800 |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 100 |
$23.00 | $2,300.00 | 100 |
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||